We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+8.64%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$622B
AUM Growth
+$11.2B
Cap. Flow
-$16.1B
Cap. Flow %
-2.59%
Top 10 Hldgs %
26.59%
Holding
3,066
New
113
Increased
1,569
Reduced
1,081
Closed
107

Top Buys

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$1.6B
2
VZ icon
Verizon
VZ
+$1.3B
3
USB icon
US Bancorp
USB
+$1.26B
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$1.26B
5
LRCX icon
Lam Research
LRCX
+$1.18B

Sector Composition

Rank Sector Weight
1 Technology 26.7%
2 Healthcare 19.64%
3 Financials 12.71%
4 Consumer Discretionary 10.95%
5 Communication Services 7.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WPP icon
1251
WPP
WPP
$5.82B
$3.65M ﹤0.01%
74,308
+5,160
+7% +$246K
GMS
1252
DELISTED
GMS Inc
GMS
$3.65M ﹤0.01%
73,275
+475
+0.7% +$22.8K
STOK icon
1253
Stoke Therapeutics
STOK
$2.02B
$3.65M ﹤0.01%
395,107
-17,236
-4% -$179K
SSB icon
1254
SouthState Bank Corp
SSB
$10.8B
$3.64M ﹤0.01%
47,713
+2,169
+5% +$182K
HP icon
1255
Helmerich & Payne
HP
$4.29B
$3.6M ﹤0.01%
72,645
-4,499
-6% -$214K
PAX icon
1256
Patria Investments
PAX
$1.88B
$3.59M ﹤0.01%
257,860
+3,904
+2% +$52.8K
LEA icon
1257
Lear
LEA
$8.16B
$3.57M ﹤0.01%
28,764
-553
-2% -$73.3K
HLIO icon
1258
Helios Technologies
HLIO
$2.66B
$3.48M ﹤0.01%
63,948
-569
-0.9% -$30.7K
STOR
1259
DELISTED
STORE Capital Corporation
STOR
$3.46M ﹤0.01%
107,965
+12,310
+13% +$391K
HOOD icon
1260
Robinhood
HOOD
$89.3B
$3.45M ﹤0.01%
423,797
-262,954
-38% -$2.58M
MMS icon
1261
Maximus
MMS
$2.94B
$3.43M ﹤0.01%
46,749
+1,791
+4% +$116K
INGR icon
1262
Ingredion
INGR
$6.54B
$3.42M ﹤0.01%
34,967
+2,279
+7% +$210K
AVNS
1263
DELISTED
Avanos Medical
AVNS
$3.42M ﹤0.01%
126,401
-656
-0.5% -$16K
CBSH icon
1264
Commerce Bancshares
CBSH
$8.61B
$3.39M ﹤0.01%
57,713
+1,749
+3% +$102K
EQRX
1265
DELISTED
EQRx, Inc. Common Stock
EQRX
$3.39M ﹤0.01%
1,377,610
-100,730
-7% -$397K
KOD icon
1266
Kodiak Sciences
KOD
$2.72B
$3.38M ﹤0.01%
472,013
-273,966
-37% -$1.97M
MAN icon
1267
ManpowerGroup
MAN
$2.61B
$3.36M ﹤0.01%
40,342
+550
+1% +$44.1K
DOCN icon
1268
DigitalOcean
DOCN
$15.6B
$3.35M ﹤0.01%
131,352
+984
+0.8% +$30.8K
CVAC
1269
DELISTED
CureVac
CVAC
$3.34M ﹤0.01%
+553,865
New +$4.09M
DLB icon
1270
Dolby
DLB
$5.84B
$3.34M ﹤0.01%
47,339
-852
-2% -$58.7K
QTRX icon
1271
Quanterix
QTRX
$135M
$3.33M ﹤0.01%
240,558
-26,645
-10% -$307K
TTEK icon
1272
Tetra Tech
TTEK
$9.09B
$3.32M ﹤0.01%
114,370
+3,295
+3% +$95.2K
NWS icon
1273
News Corp Class B
NWS
$17.7B
$3.31M ﹤0.01%
179,328
PD icon
1274
PagerDuty
PD
$932M
$3.3M ﹤0.01%
124,118
+2,962
+2% +$70K
SHOO icon
1275
Steven Madden
SHOO
$3.49B
$3.29M ﹤0.01%
103,074
+22,929
+29% +$717K

Similar funds

T. Rowe Price Associates's Q4 2022 Portfolio in Review

As of Q4 2022, T. Rowe Price Associates held 3,066 positions worth $622B, up 1.8% from $610B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

T. Rowe Price Associates's Q4 2022 filing shows 113 new, 1,569 increased, 1,081 reduced and 107 closed positions. Its largest new stake was GE HealthCare: 6,360,001 shares worth $371M. The largest sale was Amazon, an estimated $6.33B.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

  • T. Rowe Price Associates's largest Q4 2022 buy was GE HealthCare: 6,360,001 shares worth $371M.
  • T. Rowe Price Associates added most to JPMorgan Chase in Q4 2022, an estimated $1.6B increase.
  • T. Rowe Price Associates's biggest Q4 2022 reduction was Amazon, cutting an estimated $6.33B.
  • T. Rowe Price Associates fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $3.44B.
  • T. Rowe Price Associates's ten largest holdings make up 27% of its $622B portfolio in Q4 2022.
  • T. Rowe Price Associates opened 113 new positions and closed 107 in Q4 2022.
  • T. Rowe Price Associates's portfolio value rose 1.8% quarter-over-quarter to $622B.

Based on T. Rowe Price Associates's 13F filing for Q4 2022, filed 14 Feb 2023.